Search clinical trials for: Evening only administration of insulin glargine
Total 599 results
-
Johns Hopkins UniversityTerminatedHypoglycemia | Type 1 DiabetesUnited States
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 DiabetesUnited States
-
SanofiTerminated
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
University of Maryland, BaltimoreCompletedDiabetic KetoacidosisUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Ottawa Hospital Research InstituteCompleted
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
SanofiCompletedDiabetes Mellitus Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
SanofiCompleted
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); University of TorontoCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Medical University of GrazCompletedDiabetes Mellitus, Type 2Austria
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
IRCCS San RaffaeleTerminatedType 2 Diabetes Mellitus | Peripheral Vascular DiseaseItaly
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
Lannett Company, Inc.Parexel; FARMOVS (Pty) LtdCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusSouth Africa
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiTerminatedAMICanada, Brazil, United States, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Canada, Denmark, Hungary, Serbia, Germany, Greece, Romania, Estonia, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, United Kingdom, Ireland, France, South Africa, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Netherlands, Hungary, France, Bulgaria, Canada, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
SanofiCompletedType 1 Diabetes MellitusJapan
-
Novo Nordisk A/SRecruitingObesity | Diabetes Mellitus, Type 2United States, Spain, Portugal, Italy, Greece, Romania, Slovakia, Czechia, South Africa, Ukraine
-
Indonesia UniversityCompletedDiabetes MellitusIndonesia
-
SanofiCompleted
-
Universidad de GuanajuatoCompleted
-
Ain Shams UniversityRecruitingChronic Kidney DiseasesEgypt
-
Novo Nordisk A/SCompletedHealthy | Diabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
University of PittsburghSanofiCompletedHyperglycemia | Type 2 DiabetesUnited States
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico